XML 16 R9.htm IDEA: XBRL DOCUMENT
v3.21.4

SHARE EXCHANGE AND ASSIGNMENT | 12 Months Ended
--- | ---
Sep. 30, 2021
Share Exchange And Assignment [Abstract] |
SHARE EXCHANGE AND ASSIGNMENT [Text Block] | 4. SHARE EXCHANGE AND ASSIGNMENT Psilocybinlabs Ltd. ("PL") was incorporated under the laws of the province of British Columbia on April 25, 2019, with the incorporator share being held by a company controlled by the CEO of the Company. On May 17, 2019, this share was transferred to the Company. On April 25, 2019, PL entered into a confirmatory assignment and waiver (the "CAW") with an individual, which was amended and restated on May 17, 2019. Pursuant to the amended and restated CAW, this individual assigned all of the right, title and interest, including all other intellectual property rights (the Rights, as described) to PL. As compensation for the assignment of the Rights, PL issued 100,000 common shares valued at $2,000 to this individual. On August 7, 2019, the Company then purchased the 100,000 common shares of PL by issuing 100,000 common shares of the Company valued at $2,000, with the reacquisition being recorded as an asset acquisition.

X
- Definition The disclosure of share exchange and assignment. + References No definition available. + Details
Name: | drug_DisclosureOfShareExchangeAndAssignmentExplanatory
Namespace Prefix: | drug_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | drug_ShareExchangeAndAssignmentAbstract
Namespace Prefix: | drug_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration